| Application number | Title of the application | Filing Date | Status |
|---|
| 10/089862 | Trdl-1-gamma, a novel tumor necrosis-like ligand | Apr 1, 2002 | Abandoned |
Array
(
[id] => 729110
[patent_doc_number] => 07041786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/107814
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8852
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041786.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107814 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | Mar 27, 2002 | Issued |
Array
(
[id] => 6865184
[patent_doc_number] => 20030190710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Control of glycoforms in IgG'
[patent_app_type] => new
[patent_app_number] => 10/109117
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4370
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109117 | Control of glycoforms in IgG | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6791909
[patent_doc_number] => 20030087253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Polynucleotide markers for ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/113234
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15738
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113234 | Polynucleotide markers for ovarian cancer | Mar 27, 2002 | Abandoned |
Array
(
[id] => 7306817
[patent_doc_number] => 20040116667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes'
[patent_app_type] => new
[patent_app_number] => 10/468665
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7815
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468665 | TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes | Mar 14, 2002 | Issued |
Array
(
[id] => 6846897
[patent_doc_number] => 20030166064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer'
[patent_app_type] => new
[patent_app_number] => 10/099926
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70826
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099926 | Compositions and methods for the therapy and diagnosis of colon cancer | Mar 13, 2002 | Abandoned |
Array
(
[id] => 6791906
[patent_doc_number] => 20030087250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/097340
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41013
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097340 | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | Mar 13, 2002 | Abandoned |
Array
(
[id] => 289144
[patent_doc_number] => 07547759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Induction of tumor immunity by variants of folate binding protein'
[patent_app_type] => utility
[patent_app_number] => 10/094097
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 65797
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094097 | Induction of tumor immunity by variants of folate binding protein | Mar 7, 2002 | Issued |
| 09/646478 | Methods for the diagnosis and treatment of lung cancer | Mar 3, 2002 | Abandoned |
Array
(
[id] => 489092
[patent_doc_number] => 07214533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Polynucleotide useful for modulating cancer cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/467436
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 16079
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467436 | Polynucleotide useful for modulating cancer cell proliferation | Feb 28, 2002 | Issued |
Array
(
[id] => 6715829
[patent_doc_number] => 20030027177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Human DNA mismatch repair proteins'
[patent_app_type] => new
[patent_app_number] => 10/079429
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14422
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079429 | Human DNA mismatch repair proteins | Feb 21, 2002 | Abandoned |
| 10/031620 | Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody | Feb 20, 2002 | Abandoned |
Array
(
[id] => 6654028
[patent_doc_number] => 20030077248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Cell therapy method for the treatment of tumors'
[patent_app_type] => new
[patent_app_number] => 10/080013
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14943
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080013 | Cell therapy method for the treatment of tumors | Feb 18, 2002 | Abandoned |
Array
(
[id] => 6654198
[patent_doc_number] => 20030077289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Use of cell-penetrating peptides to generate antitumor immunity'
[patent_app_type] => new
[patent_app_number] => 10/077555
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18946
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077555 | Use of cell-penetrating peptides to generate antitumor immunity | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6048611
[patent_doc_number] => 20020169121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Inhibition of ATF2 activity to treat cancer'
[patent_app_type] => new
[patent_app_number] => 10/076905
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29057
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076905 | Inhibition of ATF2 activity to treat cancer | Feb 13, 2002 | Issued |
Array
(
[id] => 6851349
[patent_doc_number] => 20030143552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers'
[patent_app_type] => new
[patent_app_number] => 10/071510
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34905
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071510 | Compositions and methods for the identification, assessment, prevention and therapy of human cancers | Feb 7, 2002 | Issued |
Array
(
[id] => 6735440
[patent_doc_number] => 20030013075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'MART-1 compounds for therapy and diagnosis and methods for using same'
[patent_app_type] => new
[patent_app_number] => 10/066474
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23876
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10066474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/066474 | MART-1 compounds for therapy and diagnosis and methods for using same | Jan 30, 2002 | Abandoned |
Array
(
[id] => 6791901
[patent_doc_number] => 20030087245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/058513
[patent_app_country] => US
[patent_app_date] => 2002-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29376
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058513 | Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancer | Jan 23, 2002 | Abandoned |
Array
(
[id] => 6715823
[patent_doc_number] => 20030027171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Cell cycle regulator protein'
[patent_app_type] => new
[patent_app_number] => 10/051409
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9537
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051409 | Cell cycle regulator protein | Jan 17, 2002 | Abandoned |
| 09/889771 | Polypeptide | Jan 13, 2002 | Abandoned |